MedPath

The effect of low energy availability and low carbohydrate availability on hormone status, metabolism and performance in elite race walkers ('Supernova 4)

Not Applicable
Conditions
High-performance athlete nutrition
Reproductive hormones (testosterone, LH)
Bone metabolism
Metabolic hormones (T3, IGF1. leptin, cortisol)
Diet and Nutrition - Other diet and nutrition disorders
Metabolic and Endocrine - Normal metabolism and endocrine development and function
Musculoskeletal - Normal musculoskeletal and cartilage development and function
Registration Number
ACTRN12618001974291
Lead Sponsor
Australian Catholic University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Male
Target Recruitment
24
Inclusion Criteria

Elite male race walkers who meet criteria to compete in IAAF sanctioned national and international standard races and are in training for the 2019 season.
We anticipate that most of these athletes will have participated in previous Supernova studies

Exclusion Criteria

Race walkers with diagnosed medical conditions involving thyroid function or other chronic disturbances of metabolic rate
Race walkers with symptoms of chronic LEA/RED-S (e.g. suppressed metabolic rate, low BMD)
Race walkers who are unable to complete the training or testing protocols

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
RMR<br>measured using Douglas bag analysis [At the beginning of:<br>Phase 1 (screening)<br><br>At the end of:<br>Phase 2 (harmonisation)<br>Phase 3 (intervention)<br>Phase 4 (refeeding)<br>];25 km long walk protocol to assess bone and calcium metabolism (CTX, PINP, OC).<br>This is a hybrid laboratory/field test at ~75%VO2max.[At the end of:<br>Phase 2 (harmonisation)<br>Phase 3 (intervention)<br>Phase 4 (refeeding)];Bone metabolism<br> (CTX, PINP, OC)<br><br>Venous blood samples will be collected and analysed using ELISA kits.[During 25 km walks at time points:<br>Fasting (120min before exercise)<br>Immediately before exercise<br>Immediately after exercise<br>1h after exercise<br>3h after exercise]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath